According to this hypothesis, the paradoxical adverse effects of anti-TNF-alpha treatment, such as the exacerbation of psoriatic skin lesions in patients with psoriatic arthritis receiving anti-TNF-alpha therapy, can be considered as a consequence of the disbalance between the two cytokines. Here, TNF is linked to psoriatic arthritis.